Robert A. Hiatt, MD, PhD
Publications
Screening interval and risk of invasive squamous cell cervical cancer
Authors: Miller MG; Sung HY; Sawaya GF; Kearney KA; Kinney W; Hiatt RA
Obstet Gynecol. 2003 Jan;101(1):29-37.
Advancing age and cervical cancer screening and prognosis
Authors: Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc. 2001 Nov;49(11):1499-504.
Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan
Authors: Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer. 2000 May 15;88(10):2283-9.
Evaluation of four maternal smoking questions
Authors: Kharrazi M; Epstein D; Hopkins B; Kreutzer R; Doebbert G; Hiatt R; Swan S; Eskenazi B; Pirkle JL; Bernert JT
Public Health Rep. 1999 Jan-Feb;114(1):60-70.
Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC)
Authors: Kinney W; Sung HY; Kearney KA; Miller M; Sawaya G; Hiatt RA
Gynecol Oncol. 1998 Dec;71(3):428-30.
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status
Authors: Moorman PG; Hulka BS; Hiatt RA; Krieger N; Newman B; Vogelman JH; Orentreich N
Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):483-8.
Prediagnostic serum vitamin D and breast cancer
Authors: Hiatt RA; Krieger N; Lobaugh B; Drezner MK; Vogelman JH; Orentreich N
J Natl Cancer Inst. 1998 Mar 18;90(6):461-3.
Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct
Authors: Witherell HL; Hiatt RA; Replogle M; Parsonnet J
Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):91-6.
Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group
Authors: Black SB; Shinefield HR; Lampert D; Fireman B; Hiatt RA; Polen M; Vittinghoff E
Pediatr Infect Dis J. 1991 Feb;10(2):92-6.
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group
Authors: Black SB; Shinefield HR; Fireman B; Hiatt R; Polen M; Vittinghoff E
Pediatr Infect Dis J. 1991 Feb;10(2):97-104.
Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine
Authors: Black SB; Shinefield HR; Hiatt RA; Fireman BH; Kaiser Permanente Pediatric Vaccine Study Group
Pediatr Infect Dis J. 1988 Mar;7(3):149-56.
